I wonder if patients will educate themselves that it seems to be working pretty well as monotherapy and on their own just stop taking the other pills that they were originally prescribed for combination therapy?

I wouldn't see the insurance companies complaining if patients were given leronlimab as combination therapy, but decided to stop taking the daily pills and were doing just fine on less medicine (lower cost to them).